WealthTrust Fairport’s Celgene Corp CELG Stock Holding History

WealthTrust Fairport’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-168	Closed	-$15K	–	589
2018 Q1	$15K	Buy	+168	New	+$16.1K	﹤0.01%	362
2015 Q1	–	Sell	-900	Closed	-$101K	–	470
2014 Q4	$101K	Buy	900 +690	+329%	+$72.8K	0.01%	141
2014 Q3	$20K	Hold	210	–	–	﹤0.01%	220
2014 Q2	$18K	Hold	210	–	–	﹤0.01%	205
2014 Q1	$15K	Sell	210 -60	-22%	-$4.75K	﹤0.01%	203
2013 Q4	$23K	Buy	270 +60	+29%	+$4.75K	﹤0.01%	168
2013 Q3	$16K	Hold	210	–	–	﹤0.01%	235
2013 Q2	$12K	Buy	+210	New	+$12.6K	﹤0.01%	240

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WealthTrust Fairport's CELG Position: Q2 2018 in Review

WealthTrust Fairport sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 168 shares — an estimated $15K sold.

WealthTrust Fairport first reported a position in CELG in Q2 2013 and held it in 8 quarters. The position peaked at $101K in Q4 2014. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

WealthTrust Fairport reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
WealthTrust Fairport sold 168 Celgene Corp shares in Q2 2018, an estimated $15K.
WealthTrust Fairport first reported a position in Celgene Corp in Q2 2013 and held it in 8 quarters.
WealthTrust Fairport's Celgene Corp position peaked at $101K in Q4 2014.
1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on WealthTrust Fairport's 13F filing for Q2 2018, filed 28 Aug 2018.